ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
ConvaTec Dividend Announcement
• ConvaTec announced a semi annually dividend of $0.07 per ordinary share which will be made payable on 2024-10-21. Ex dividend date: 2024-08-23
• ConvaTec annual dividend for 2024 was $0.25
• ConvaTec annual dividend for 2023 was $0.25
• ConvaTec's trailing twelve-month (TTM) dividend yield is 2.25%
• ConvaTec's payout ratio for the trailing twelve months (TTM) is 65.88%
• ConvaTec's dividend growth over the last five years (2018-2023) was 0.96% year
ConvaTec Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-23 | $0.07 | semi annually | 2024-10-21 |
2024-04-25 | $0.18 | semi annually | 2024-06-07 |
2023-08-17 | $0.07 | semi annually | 2023-10-13 |
2023-04-10 | $0.18 | semi annually | 2023-06-09 |
2022-08-25 | $0.06 | semi annually | 2022-10-21 |
2022-03-31 | $0.16 | semi annually | 2022-06-03 |
2021-09-02 | $0.07 | semi annually | 2021-10-28 |
2021-04-05 | $0.16 | semi annually | 2021-05-27 |
2020-09-03 | $0.07 | semi annually | 2020-10-29 |
2020-04-02 | $0.15 | semi annually | 2020-05-29 |
2019-09-05 | $0.07 | semi annually | 2019-10-31 |
2019-04-04 | $0.16 | semi annually | 2019-05-31 |
2018-09-06 | $0.07 | semi annually | 2018-10-26 |
2018-04-05 | $0.17 | semi annually | 2018-05-31 |
2017-09-07 | $0.06 | semi annually | 2017-11-03 |
ConvaTec Dividend per year
ConvaTec Dividend growth
ConvaTec Dividend Yield
ConvaTec current trailing twelve-month (TTM) dividend yield is 2.25%. Interested in purchasing ConvaTec stock? Use our calculator to estimate your expected dividend yield:
ConvaTec Financial Ratios
ConvaTec Dividend FAQ
Other factors to consider when evaluating ConvaTec as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy ConvaTec stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: ConvaTec's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, ConvaTec publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, ConvaTec distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from ConvaTec are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: ConvaTec sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, ConvaTec distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: ConvaTec declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of ConvaTec's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review ConvaTec's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.